Organogenesis Holdings Inc (NASDAQ:ORGO)’s traded shares stood at 0.61 million during the last session, with the company’s beta value hitting 1.70. At the close of trading, the stock’s price was $2.90, to imply a decrease of -2.36% or -$0.07 in intraday trading. The ORGO share’s 52-week high remains $6.71, putting it -131.38% down since that peak but still an impressive 21.38% since price per share fell to its 52-week low of $2.28.
Analysts have given a consensus recommendation of Buy for Organogenesis Holdings Inc (ORGO), translating to a mean rating of 1.50. Of 3 analyst(s) looking at the stock, 0 analyst(s) give ORGO a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.01.
Organogenesis Holdings Inc (NASDAQ:ORGO) trade information
After registering a -2.36% downside in the last session, Organogenesis Holdings Inc (ORGO) has traded red over the past five days. The 5-day price performance for the stock is -5.84%, and -35.98% over 30 days. With these gigs, the year-to-date price performance is -9.37%.
The extremes give us $6 and $6 for target low and target high price respectively. As such, ORGO has been trading -106.9% off suggested target high and -106.9% from its likely low.
Organogenesis Holdings Inc (ORGO) estimates and forecasts
The rating firms project that company’s revenue will grow 2.48% compared to the previous financial year.
Revenue forecast for the current quarter as set by 3 analysts is 103.4M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 142.8M.Earnings reports from the last fiscal year show that sales brought in 130.23M and 115.18M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -20.60% before jumping 23.98% in the following quarter.
ORGO Dividends
Organogenesis Holdings Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is SOLEUS CAPITAL MANAGEMENT, L.P. with 11.52 million shares, or about 8.6888% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $32.25 million.
We also have iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Organogenesis Holdings Inc (ORGO) shares. Going by data provided on Mar 31, 2025 , iShares Trust-iShares Russell 2000 ETF holds roughly 1.85 shares. This is just over 1.46% of the total shares, with a market valuation of $5.37 million. Data from the same date shows that the other fund manager holds a little less at 1.46, or 1.15% of the shares, all valued at about 4.24 million.
